Local treatment options for Stage IV breast cancer

Afonin G.V.; Ragulin Iu.A.

doi:https://doi.org/10.17116/onkolog20165172-77

Close metadata

Recommended articles:

Capsular contracture after reconstructive plastic surgery for breast cancer. P.A. Herzen Journal of Oncology. 2024;(6):78-83

Giant pericranial sinus with extensive occipital calvarium defect. Burdenko's Journal of Neurosurgery. 2024;(6):77-87

Surgical treatment of ascending aortic dissection after previous thoracic endovascular aortic repair and proximal stent-graft induced new entry. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):682-685

NDRG1 protein expression in breast cancer samples, relationship with lymph nodes metastasis. Russian Journal of Archive of Pathology. 2024;(6):36-42

Treatment of knee osteoarthritis with autologous stromal-vascular fraction of adipose tissue. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(4):27-37

Conservative treatment for avascular necrosis of the femoral head: a systematic review. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(4):52-67

Impact of tumor size on actuarial survival of patients with primary breast sarcoma: a case-control study. Pirogov Russian Journal of Surgery. 2024;(12):38-43

Influence of non-opiate analgesia on postoperative pain intensity and patient satisfaction. Pirogov Russian Journal of Surgery. 2024;(12):74-80

Difficulties in surgical treatment of fixed cardiofundal axial esophageal hiatal hernia. Pirogov Russian Journal of Surgery. 2024;(12):105-108

Assessment of risk factors for breast cancer development in women living in the Saratov region. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):100-106

Abstract:

Systemic drug therapy is a basic treatment for Stage IV breast cancer. The problem with local options to treat patients with BC and distant metastases has not been fully solved. The review gives the results of treatment for metastatic breast cancer, which have been obtained by investigators using different procedures. Most investigations given in the present-day literature suggest that survival rates significantly improve when patients receive chemical and radiation treatment regimens.

Keywords:

breast cancer

Stage IV

surgery

radiation therapy

Authors:

Afonin G.V.

A.F. Tsyb Medical Radiology Research Center, Branch, National Medical Radiology Research Center, Ministry of Health of the Russian Federation, Obninsk, Russia

Ragulin Iu.A.

Meditsinskiĭ radiologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossii, Obninsk

Close metadata

References:

Sostoyanie onkologicheskoi pomoshchi Rossii v 2014 godu. Pod red. Kaprina A.D., Starinskogo V.V., Petrovoi G.V. M.: MNIOI im. P.A. Gertsena — filial FGBU «NMIRTs» Minzdrava Rossii; 2015:5,11.
Qian LW, Mizumoto K, Urashima T, Nagai E, Maehara N, Sato N et al. Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res. 2002;8(4):1223-1227.
Jung J, Hwang S, Hwang J, Oh E, Park S, Han I. Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. Eur J Cancer. 2007;43(7):1214-1224. doi:10.1016/j.ejca.2007.01.034.
Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O’Reilly MS. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res. 2001;61(5):2207-2211.
Zhang X, Li X, Zhang N, Yang Q, Moran MS. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial—mesenchymal transition. Biochem Biophys Res Commun. 2011;412(1):188-192. doi:10.1016/j.bbrc.2011.07.074.
Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus D et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res. 2002;8(7):2073-2084.
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781-791. doi:10.1056/nejmoa040766.
Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM et al. Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005;23(7):1420-1430. doi:10.1200/jco.2005.08.140.
Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res. 2004;64(6):2205-2211. doi:10.1158/0008-5472.can-03-2646.
Ali D, Le Scodan R. Treatment of the primary tumor in breast cancer patients with synchronous metastases. Ann Oncol. 2010;22(1):9-16. doi:10.1093/annonc/mdq301.
Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13(6):776-782. doi:10.1245/aso.2006.03.033.
Salo M. Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand. 1992;36(3):201-220. doi:10.1111/j.1399-6576.1992.tb03452.x.
Hallissey MT, Allum WH, Roginski C, Fielding JW. Palliative surgery for gastric cancer. Cancer. 1988;62(2):440-444. doi:10.1002/1097-0142(19880715)62:2<440::aid-cncr2820620232>3.0.co;2-n.
Rosen SA, Buell JF, Yoshida A, Kazsuba S, Hurst R, Michelassi F. et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000;135(5):530-534;discussion 534-535. doi:10.1001/archsurg.135.5.530.
Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Sekido H et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery. 2004;136(3):650-659. doi:10.1016/j.surg.2004.02.012.
Dauplat J, Le Bouedec G, Pomel C, Scherer C. Cytoreductive surgery for advanced stages of ovarian cancer. Semin Surg Oncol. 2000;19(1):42-48. doi:10.1002/1098-2388(200007/08)19:1<42::aid-ssu7>3.0.co;2-m.
Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, Mc Grath PC et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345(23):1655-169. doi:10.1056/nejmoa003013.
Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet. 2001;358(9286):966-970. doi:10.1016/s0140-6736(01)06103-7.
Essner R, Lee JH, Wanek LA, Itakura H, Morton DL. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg. 2004;139(9):961. doi:10.1001/archsurg.139.9.961.
Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132(4):620-627. doi:10.1067/msy.2002.127544.
Lang JE, Tereffe W, Mitchell MP, Rao R, Feng L, Meric-Bernstam F et al. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol. 2013;20(6):1893-1899. doi:10.1245/s10434-012-2844-y.
Samiee S, Berardi P, Bouganim N, Vandermeer L, Arnaout A, Dent S et al. Excision of the primary tumour in patients with metastatic breast cancer: a clinical dilemma. Curr Oncol. 2012;19(4):e270-e279. doi:10.3747/co.19.974.
Di Lascio S, Pagani O. Oligometastatic breast cancer: a shift from palliative to potentially curative treatment? Breast Care (Basel). 2014;9(1):7-14. doi:10.1159/000358750.
Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006;24(18):2743-2749. doi:10.1200/jco.2005.04.2226.
Hazard HW, Gorla SR, Scholtens D, Kiel K, Gradishar WJ, Khan SA. Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Cancer. 2008;113(8):2011-2019. doi:10.1002/cncr.23870.
Sukhot'ko A.S., Zikiryakhodzhaev A.D., Bolotina L.V., Sidorov D.B., Tyshchenko E.V. Khirurgicheskii etap lecheniya v kompleksnoi terapii u bol'nykh generalizovannym rakom molochnoi zhelezy. Onkologiya. Zhurnal im. P.A. Gertsena. 2014;2(1):24-29.
Chernova E.V., Khailenko V.A., Artamonova E.V., Laktionov K.P., Trofimova O.P., Manzyuk L.V., Komov D.V. Tselesoobraznost' udaleniya pervichnoi opukholi u bol'nykh s vpervye vyyavlennym disseminirovannym rakom molochnoi zhelezy. Rossiiskii onkologicheskii zhurnal. 2013;2:27-30.
Le Scodan R, Stevens D, Brain E, Floiras JL, Cohen-Solal Ch, De La Lande B et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. J Clin Oncol. 2009;27(9):1375-1381. doi:10.1200/jco.2008.19.5396.
Bourgier C, Khodari W, Vataire AL, Pessoa EL, Dunant A, Delaloge S et al. Breast radiotherapy as part of locoregional treatments in stage IV breast cancer patients with oligometastatic disease. Radiother Oncol. 2010;96(2):199-203. doi:10.1016/j.radonc.2010.02.028.
Nguyen DH, Truong PT, Alexander C, Walter CV, Hayashi E, Christie J et al. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at iagnosis? Int J Radiat Oncol Biol Phys. 2012;84(1):39-45. doi:10.1016/j.ijrobp.2011.11.046.
Ly BH, Vlastos G, Rapiti E, Vinh-Hung V, Nguyen NP. Local-regional radiotherapy and surgery is associated with a significant survival advantage in metastatic breast cancer patients. Tumori. 2010;96(6):947-954.
Le Scodan R, Ali D, Stevens D. Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous. BMC Cancer. 2010;10:630. doi:10.1186/1471-2407-10-630.
Madani I, De Neve W, Mareel M. Les rayons ionisants provoquent-ils des activités proinvasives et prométastatiques? Bull Cancer. 2008;95(3):292-300. doi:10.1684/bdc.2008.0598.
Ruiterkamp J, Ernst MF, Van De Poll-Franse LV, Bosscha K, Tjan-Heijnen VCG, Voogd AC. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol. 2009;35(11):1146-1151. doi:10.1016/j.ejso.2009.03.012.
Fields RC, Jeffe DB, Trinkaus K, Zhang Q, Arthur C, Aft R et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol. 2007;14(12):3345-3351. doi:10.1245/s10434-007-9527-0.
Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247(5):732-738. doi:10.1097/sla.0b013e3181656d32.
Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol. 2007;14(8):2187-2194. doi:10.1245/s10434-007-9438-0.